Andrew Baker, PA
Surgical · Columbus, OHNPI 1427318393
Payments from drug & device makers
Across 786 payments — averaging $130.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$23K
- Sanofi$14K
- E.r. Squibb & Sons, L.L.C.$13K
- Novartis$11K
- Sun Pharmaceutical Industries Inc.$9K
- Incyte Corporation$8K
- plus $23K from 28 others
What the payments were for
- Consulting fees$34,89834%
- Speaking & faculty fees$32,04831%
- Travel & lodging$18,43418%
- Food & beverage$16,30016%
- Education$5221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 94 | $23,334 |
| Sanofi | 51 | $13,978 |
| E.r. Squibb & Sons, L.L.C. | 53 | $12,787 |
| Novartis | 62 | $11,374 |
| Sun Pharmaceutical Industries Inc. | 44 | $9,366 |
| Incyte Corporation | 44 | $8,031 |
| Johnson & Johnson | 62 | $6,498 |
| Arcutis Biotherapeutics, Inc. | 30 | $6,206 |
| Boehringer Ingelheim | 7 | $2,303 |
| AbbVie | 149 | $2,184 |
| LEO Pharma Inc. | 28 | $1,930 |
| UCB, Inc. | 39 | $855 |
| Sanofi US Services Inc. | 1 | $823 |
| Dermavant Sciences, Inc. | 13 | $557 |
| Lilly USA, LLC | 24 | $435 |
| Organon | 13 | $277 |
| Galderma Laboratories, L.p. | 21 | $272 |
| Pfizer | 11 | $199 |
| Janssen Scientific Affairs, LLC | 3 | $100 |
| Mayne Pharma Commercial LLC | 8 | $97 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Biofrontera Inc. | 4 | $79 |
| Botanix SB Inc | 3 | $75 |
| Amgen | 3 | $65 |
| Almirall LLC | 2 | $48 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $36 |
| VYNE Pharmaceuticals Inc. | 2 | $34 |
| Bristol Myers Squibb | 1 | $27 |
| Abbott | 1 | $23 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$102,202 in reported general payments places this provider in the 95th percentile of 294 surgical providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 57 | $209,202 |
| Fluorouracil | 44 | $3,954 |
| Fluocinonide | 43 | $2,229 |
| Triamcinolone Acetonide | 90 | $765 |
| Ketoconazole | 29 | $388 |
| Doxycycline Hyclate | 42 | $326 |
| Mupirocin | 47 | $286 |
| Hydroxyzine Hcl | 29 | $236 |
| Azithromycin | 55 | $209 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $82 |
| Minoxidil | 16 | $77 |
| Tramadol Hcl | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other surgical in Columbus
- Leigha GarringerColumbus$13K
- Andrew ConkleColumbus$3K
- Gerald InksColumbus$3K
- Sean FinneranColumbus$2K
- Gina VoitovColumbus$2K
- Brian ValusColumbus$2K
- Kyle SmithColumbus$2K
- Jason BrownCleveland$345K
- Michael KuehneToledo$35K
- Joseph EhrhardCincinnati$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.